Phychem Technologies (BSE 544902)₹41.90+1.95%Other Industrial Products
For the year to Mar 2026, sales were ₹56.62 Cr and net profit ₹4.07 Cr.
Company filings, standalone accounts
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 42.36 | 47.12 | 50.41 | 56.62 |
| Expenses | 40.36 | 44.17 | 45.95 | 50.36 |
| Operating Profit | 1.89 | 2.82 | 4.38 | 6.13 |
| OPM % | 4.5% | 6.0% | 8.7% | 10.9% |
| Other Income | 0.91 | 0.61 | 0.84 | 1.01 |
| Interest | 0.63 | 0.65 | 0.90 | 1.06 |
| Depreciation | 0.34 | 0.41 | 0.51 | 0.53 |
| Profit before tax | 1.82 | 2.36 | 3.80 | 5.53 |
| Tax % | 27.9% | 28.3% | 25.8% | 26.2% |
| Exceptional items | 0.00 | 0.00 | 0.03 | 0.00 |
| Net Profit | 1.31 | 1.68 | 2.83 | 4.07 |
| EPS (Rs) | 45.65 | 58.46 | 98.09 | 5.44 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.28 | 0.28 | 0.28 | 7.54 |
| Reserves | 4.86 | 6.55 | 9.39 | 6.24 |
| Borrowings | 4.92 | 5.62 | 4.60 | 5.91 |
| Other Liabilities | 4.66 | 5.38 | 6.49 | 5.60 |
| Total Liabilities | 14.72 | 17.83 | 20.76 | 25.29 |
| Fixed Assets | 4.06 | 6.15 | 6.07 | 5.77 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.02 |
| Investments | 0.07 | 0.07 | 0.07 | 0.07 |
| Other Assets | 10.59 | 11.61 | 14.62 | 19.43 |
| Inventories | 4.01 | 4.47 | 6.22 | 9.55 |
| Trade receivables | 4.81 | 4.70 | 4.56 | 5.84 |
| Cash & equivalents | 0.18 | 0.16 | 0.21 | 0.68 |
| Total Assets | 14.72 | 17.83 | 20.76 | 25.29 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | 0.51 | 2.57 | 2.54 | 0.79 |
| Cash from investing activity | −0.59 | −2.80 | −0.62 | −0.64 |
| Cash from financing activity | 0.00 | 0.20 | −1.86 | 0.31 |
| Net cash flow | −0.06 | −0.01 | 0.04 | 0.46 |
| Capex | 0.58 | 2.49 | 0.42 | 0.24 |
| Free cash flow | −0.09 | 0.08 | 2.13 | 0.53 |
| CFO / OP % | 48.9% | 106.9% | 74.0% | 32.9% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 42 | 37 | 34 | 39 |
| Inventory days | 41 | 42 | 57 | 79 |
| Days payable | 34 | 33 | 33 | 31 |
| Cash conversion cycle | 49 | 46 | 57 | 87 |
| Working capital days | 16 | 17 | 33 | 47 |
| ROCE % | — | 26.9% | 35.0% | 39.0% |
Phychem Technologies' sales for the year to Mar 2026 were ₹56.62 Cr.
Net profit for the year to Mar 2026 was ₹4.07 Cr. Earnings per share over the same trailing period were ₹5.44.
Phychem Technologies reported borrowings of ₹5.91 Cr at Mar 2026, against cash and equivalents of ₹0.68 Cr.
Cash from operations was ₹0.79 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.53 Cr.